Figure 3.

Associations between histopathologic prognostic markers and heterogeneity phenotypes. Associations between histopathologic prognostic markers and heterogeneity phenotypes identified in the discovery cohort. Degree of phenotypic heterogeneity in well, moderately, and poorly differentiated tumors (A). Percent of estrogen receptor distribution for women in low, medium, and high heterogeneity phenotypes (B). Degree of phenotypic heterogeneity in tumors with low, moderate and high mitotic stage (C).